RxDoctor Payments Data

Kimberly Ditz

Psychiatric/Mental Health · Bradford, PANPI 1780889980

Payments from drug & device makers

$3,261in general payments, 2019–2025

Across 222 payments — averaging $14.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$857
  • Alkermes, Inc.$465
  • Axsome Therapeutics, Inc.$376
  • Lundbeck LLC$250
  • Corium, LLC$154
  • Takeda Pharmaceuticals U.S.A., Inc.$137
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$3,19998%
  • Education$622%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,261 in reported general payments places this provider in the 85th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$15,101
Medicare patients
53
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole17$35,456
TrintellixVortioxetine Hydrobromide33$18,453
BelsomraSuvorexant12$5,098
MydayisDextroamphetamine/Amphetamine20$3,868
Ziprasidone Hcl86$3,629
Atomoxetine Hcl33$3,359
Divalproex Sodium ErDivalproex Sodium53$3,301
Clozapine42$3,149
Duloxetine Hcl221$3,137
Trazodone Hcl229$2,743
Buspirone Hcl165$2,731
Aripiprazole108$2,660
Venlafaxine Hcl ErVenlafaxine Hcl178$2,175
Bupropion XlBupropion Hcl135$2,087
Lurasidone Hcl30$2,014

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$123$35,45617 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$137$18,45333 claims
MerckBelsomra$58$5,09812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Bradford

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →